Transforming growth factor‐β regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts
- 1 August 1989
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 72 (4) , 486-491
- https://doi.org/10.1111/j.1365-2141.1989.tb04310.x
Abstract
Summary Three growth factors present in platelets, namely platelet‐derived growth factor (PDGF), transforming growth factor‐β (TGF‐β) and epidermal growth factor (EGF), have been implicated in the pathogenesis of bone marrow fibrosis frequently associated with myeloproliferative disorders. In this study, regulation of the proliferation, as well as collagen and fibronectin synthesis from marrow fibroblasts by TGF‐β was investigated. TGF‐β alone at high plating density stimulated the proliferation of cells at low concentrations, but rather showed inhibition at high concentrations in both MPD patients and control subjects. In the presence of PDGF, which has been confirmed to be a main growth factor for marrow fibroblasts, low concentration of TGF‐β inhibited the proliferation at low cell density, but there was no inhibition at high cell density. The synthesis of both type I and type III procollagen was enhanced by high concentrations of TGF‐β in both MPD patients and control subjects, while PDGF or EGF showed no effect. The fibronectin synthesis was also enhanced by TGF‐β, but not by PDGF or EGF. These results suggest that growth and stromal protein synthesis of fibroblasts causing marrow fibrosis are regulated by TGF‐β as well as PDGF and EGF, when these factors are released or leaked from platelets or megakaryocytes into marrow environment in MPD patients.This publication has 17 references indexed in Scilit:
- Marrow fibroblasts from patients with myeloproliferative disorders show increased sensitivity to human serum mitogensBritish Journal of Haematology, 1988
- Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-β on the growth of human marrow fibroblastsBritish Journal of Haematology, 1988
- Platelet‐derived growth factor is decreased in patients with myeloproliferative disordersAmerican Journal of Hematology, 1988
- Some recent advances in the chemistry and biology of transforming growth factor-beta.The Journal of cell biology, 1987
- Ehlers-Danlos syndrome. A variant characterized by the deficiency of pro alpha 2 chain of type I procollagenArchives of Dermatology, 1987
- The biology of platelet-derived growth factorCell, 1986
- Platelet‐derived growth factor(s) mitogenic activity in patients with myeloproliferative diseaseBritish Journal of Haematology, 1986
- Platelet-derived growth factor. Structure, function, and roles in normal and transformed cells.Journal of Clinical Investigation, 1984
- Physiological quiescence in plasma‐derived serum: Influence of platelet‐derived growth factor on cell growth in cultureJournal of Cellular Physiology, 1978
- Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteinsBiochemistry, 1971